Rosenberg, ScD, led a survey that found women who have double mastectomies
generally overestimate their likelihood of getting cancer in the healthy
E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine
significantly prolonged progression-free survival in patients with progressive
HER2-positive advanced breast cancer.
Tags: BasicResearch, BreastCancer
Eric P. Winer co-chaired an expert panel that developed a clinical practice
guideline on disease management for patients with advanced HER2-positive breast
cancer and brain metastases.
Tags: BreastCancer, CervicalCancer, OvarianCancer, GynecologicCancers
Dr. Eric Winer commented on a blood test that could reduce the number of women who need chemotherapy after tumor removal surgery.
Tags: BreastCancer, Genetics, Prevention
Tags: BreastCancer, Surgery
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: